The future of European healthcare depends on what happens now
European healthcare stands at a pivotal moment. The pandemic may feel a lifetime ago, but we are yet to fully
Read more
Research & Innovation
Putting patients at the centre of the EU health and pharmaceutical agenda
The COVID-19 crisis exposed the vulnerabilities of national healthcare systems and highlighted the importance of health policies that truly address
Read more
Policy priorities to prepare for the next health crisis – including building more resilient medical supply chains
With 7million reported COVID-19 deaths and over 19 million excess deaths estimated worldwide by January 2023, COVID-19 brought to the
Read more
Health security strategy: strengthening Europe’s pharma industry base
A resilient and dynamic ecosystem for healthcare innovation is key to strengthening the European Union. A comprehensive strategy brings patient
Read more
Enhancing the resilience and the competitiveness of the pharma supply chains to secure access to critical medicines and other medical countermeasures
When the COVID-19 pandemic hit, countries around the globe were caught off guard. In Europe, each country initially responded on
Read more
The patient at the center of all health policies
In the wake of the global COVID-19 crisis, Europe stands at a critical juncture in shaping its health policies and
Read more
Building a Strong European Health Union: Blazing a trail in the European pharmaceutical sector
The start of the decade has crystallised the importance of healthcare policy, particularly due to the COVID-19 pandemic. This global
Read more
A critical medicines act for Europe
Introduction Over the past few decades, Europe’s manufacturing base for off-patent medicines, APIs, and starting materials has gradually decreased. This
Read more